Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators

Details for Australian Patent Application No. 2005236055 (hide)

Owner TransTech Pharma, Inc.

Inventors Dankwardt, John; Andrews, Robert C.; Victory, Samuel; Arimilli, Murty N.; Qabaja, Ghassan; Mjalli, Adnan M. M.; Tian, Ye E.; Zhu, Jeff; Gaddam, Bapu R.; Subramanian, Govindan

Agent Pizzeys

Pub. Number AU-B-2005236055

PCT Pub. Number WO2005/103022

Priority 60/563,882 20.04.04 US

Filing date 20 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 6 October 2011

International Classifications

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/52 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/56 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

12 October 2006 PCT application entered the National Phase

  PCT publication WO2005/103022 Priority application(s): WO2005/103022

23 November 2006 Change of Name(s) of Applicant(s), Section 104

  Transtech Pharma Inc. The name of the applicant has been changed to TransTech Pharma, Inc.

6 October 2011 Application Accepted

  Published as AU-B-2005236055

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236059-Pyrazolo- [4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists

2005236053-Articles containing nanofibers for use as barriers